Patent assignee · DE · COMPANY

Toxogen GmbH

2Patents
2Active
2Granted
43Portfolio score

Filing activity: Sep 6, 2005 → Oct 30, 2006 · 2 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8476024B2 Botulinum neurotoxin a protein receptor and uses thereof Emerging Cross-Sectional Technologies 30 Active
US8293230B2 Transport protein which is used to introduce chemical compounds into nerve cells Emerging Cross-Sectional Technologies 12 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.